A2A腺受体激动剂,对抗剂,反向激动剂和部分激动剂
Kenneth A Jacobson1, R Rama Suresh1, Paola Oliva1
1Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, United States.
International review of neurobiology
|September 23, 2023
概括
A2A腺受体是药物开发的关键标. 基于结构的设计最近取得的进展为帕金森病,癌症免疫疗法和神经保护提供了有希望的新对手.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 与Gs合的A2A腺受体 (A2AAR) 是一个重要的药物点.
- 尽管进行了广泛的研究,但仍然存在有限的FDA批准的药物 (regadenoson, istradefylline).
- 腺素本身被用于心肌输液成像 (MPI).
研究的目的:
- 审查A2AAR连接体开发的最新进展.
- 突出基于结构的药物设计对识别新治疗剂的影响.
- 探索A2AAR对抗剂在各种疾病中的潜力.
主要方法:
- 基于结构的药物设计,利用X射线晶体学和生物物理绘图.
- 计算机化药物设计方法.
- 审查最近的药物化学努力和临床试验结果.
主要成果:
- 识别新型的,类似药物的A2AAR抗体.
- 成功的计算设计的化合物,如imaradenant (AZD4635).
- 癌症免疫疗法和神经保护 (阿尔茨海默病) 中A2AAR对抗剂的新兴潜力.
结论:
- 针对A2AAR的药物化学已经获得了动力,这是基于结构的设计所推动的.
- A2AAR对抗剂在帕金森病,癌症和神经退行性疾病方面表现有前途.
- 预计这些新型A2AAR向剂的进一步临床试验.
相关概念视频
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
906
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
906
Adrenergic Receptors: ɑ Subtype
1.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.6K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K
Adrenergic Receptors (Adrenoceptors): Classification
2.7K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.7K
Adrenergic Agonists: Therapeutic Classification
852
Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
852
Adrenergic Agonists: Direct-Acting Agents
1.6K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
1.6K


